Literature DB >> 26162474

Detection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS).

Mehmet A Saracli1, Annette W Fothergill2, Deanna A Sutton2, Nathan P Wiederhold2.   

Abstract

MALDI-TOF MS can rapidly identify microorganisms to the species level and may be able to detect antimicrobial resistance. We evaluated the ability of this technology to detect triazole resistance in Candida species.35 C. albicans, 35 C. glabrata, and 37 C. tropicalis strains were exposed to fluconazole, voriconazole, or posaconazole at two different concentrations plus a drug-free control: a midrange concentration (CLSI clinical breakpoint or epidemiologic cut-off value), and a high concentration (fluconazole 64 μg/ml, voriconazole & posaconazole 16 μg/ml). The MALDI-TOF MS spectra at these concentrations were used to create the individual composite correlation index (CCI) matrices for each isolate. When the CCI of the midrange/highest concentration was lower than that of the midrange/null concentration, the strain was classified as resistant. These results were then compared to the classifications for susceptible or resistant obtained by measuring the MICs according to the CLSI M27-A3 antifungal susceptibility testing (AFST) method.The MALDI-TOF MS assay was able to classify triazole susceptibility against all strains. Overall, essential agreement between MALDI-TOF MS and AFST varied between 54% and 97%, and was highest for posaconazole against C. glabrata. The reproducibility of the MALDI-TOF MS assay varied between 54.3 and 82.9% and was best for fluconazole against C. albicans and posaconazole against C. glabrata. Reproducibility was also higher for C. glabrata isolates compared to C. albicans and C. tropicalis.These results demonstrate that MALDI-TOF MS may be used to simultaneously determine the Candida species and classification as susceptible or resistant to triazole antifungals. Further studies are needed to refine the methodology and improve the reproducibility of this assay.
© The Author 2015. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Candida; MALDI-TOF MS; resistance; susceptibility testing

Mesh:

Substances:

Year:  2015        PMID: 26162474     DOI: 10.1093/mmy/myv046

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  20 in total

1.  Antifungal Susceptibility Testing of Aspergillus spp. by Using a Composite Correlation Index (CCI)-Based Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method Appears To Not Offer Benefit over Traditional Broth Microdilution Testing.

Authors:  Melissa R Gitman; Lisa McTaggart; Joanna Spinato; Rahgavi Poopalarajah; Erin Lister; Shahid Husain; Julianne V Kus
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

Review 2.  Invasive Candida Infections in the ICU: Diagnosis and Therapy.

Authors:  Péter Hankovszky; Domokos Társy; Nándor Öveges; Zsolt Molnár
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-11-10

Review 3.  MALDI-TOF mass spectrometry technology for detecting biomarkers of antimicrobial resistance: current achievements and future perspectives.

Authors:  Georgia Vrioni; Constantinos Tsiamis; George Oikonomidis; Kalliopi Theodoridou; Violeta Kapsimali; Athanasios Tsakris
Journal:  Ann Transl Med       Date:  2018-06

Review 4.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

Review 5.  Prophylactic Measures During Induction for Acute Myeloid Leukemia.

Authors:  Matthew W McCarthy; Thomas J Walsh
Journal:  Curr Oncol Rep       Date:  2017-03       Impact factor: 5.075

Review 6.  Mass spectrometry in research laboratories and clinical diagnostic: a new era in medical mycology.

Authors:  Hasti Kamali Sarvestani; Alireza Ramandi; Muhammad Ibrahim Getso; Taraneh Razavyoon; Javad Javidnia; Miaad Banay Golrizi; Ali-Akbar Saboor-Yaraghi; Saham Ansari
Journal:  Braz J Microbiol       Date:  2022-03-28       Impact factor: 2.214

Review 7.  Recent trends in molecular diagnostics of yeast infections: from PCR to NGS.

Authors:  Toni Gabaldón
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

8.  Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Antimicrobial Susceptibility Testing.

Authors:  Evgeny A Idelevich; Karsten Becker
Journal:  J Clin Microbiol       Date:  2021-06-16       Impact factor: 5.948

Review 9.  Matrix-Assisted Laser Desorption Ionization Time-of-Flight for Fungal Identification.

Authors:  Anna F Lau
Journal:  Clin Lab Med       Date:  2021-04-24       Impact factor: 2.172

Review 10.  MALDI-TOF MS in a Medical Mycology Laboratory: On Stage and Backstage.

Authors:  Marie-Gladys Robert; Muriel Cornet; Aurélie Hennebique; Tahinamandranto Rasamoelina; Yvan Caspar; Léa Pondérand; Marie Bidart; Harmonie Durand; Marvin Jacquet; Cécile Garnaud; Danièle Maubon
Journal:  Microorganisms       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.